St. Emlyn
APRIL 25, 2024
St.Emlyn's - Emergency Medicine #FOAMed Part 2 of our podcast on top papers from 2023/24 with @EMManchester and @docb #FOAMed @stemlyns The post Top papers podcast 2023/24. Part 2. St Emlyn’s appeared first on St.Emlyn's.
AED Leader
APRIL 25, 2024
In medical emergencies, having access to reliable and efficient automated external defibrillators (AEDs) can be a matter of life and death. One such AED that has gained significant recognition and trust is the HeartStart M5066A. This comprehensive review and analysis will delve into the features, benefits, and overall performance of the HeartStart M5066A.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
American Medical Compliance
APRIL 25, 2024
The following MRI Level 2 Training is designed to educate healthcare professionals with Level 2 clearance on proper safety guidelines when using MRIs. This advanced training not only broadens the foundational knowledge obtained in Level 1 but also equips practitioners with specialized skills to handle complex imaging scenarios and interpret subtle nuances in MRI scans.
PDC Healthcare
APRIL 25, 2024
Children in hospitals often experience anxiety, fear, and discomfort during procedures and even routine checkups. This can lead to distress, resistance, and even safety risks. Traditional methods to manage these challenges can be invasive or have limited effectiveness. Time constraints can also limit the type of methods used to manage these challenges.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
PulmCCM
APRIL 25, 2024
Patients with certain spontaneous intracerebral hemorrhages treated with minimally invasive surgery had improved functional outcomes compared to those treated with usual care, the ENRICH randomized trial showed. Treatment options for spontaneous interest cerebral hemorrhage have remained severely limited, with little improvement in outcomes over decades.
Sensible Medicine
APRIL 25, 2024
The US FDA is under tremendous political pressure to approve drugs, and indeed they tout the number of approved drugs as a measure of the quality of their work. Unfortunately, you can approve bad drugs. Selenexor is a toxic poison that does not increase survival. Belantumab causes eye damage and had to be pulled from the US market Idelalisib, copanlisib, duvelisib— the entire P13k inhibitor class —may have resulted in increased deaths.
Expert insights. Personalized for you.
120 
Let's personalize your content